{"id":"https://openalex.org/W2467389923","doi":null,"title":"Prevalence des marqueurs du virus de l\u2019hepatite b chez les patients infectes par le vih et traites par anti-retroviraux dans un pays a ressources limitees","display_name":"Prevalence des marqueurs du virus de l\u2019hepatite b chez les patients infectes par le vih et traites par anti-retroviraux dans un pays a ressources limitees","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2467389923","mag":"2467389923"},"language":"fr","primary_location":{"id":"mag:2467389923","doi":null,"is_oa":false,"landing_page_url":"https://www.ajol.info/index.php/jrsul/article/view/135083","pdf_url":null,"source":{"id":"https://openalex.org/S4212762984","display_name":"Journal de la Recherche Scientifique de l\u2019Universit\u00e9 de Lom\u00e9","issn_l":"1727-8651","issn":["1727-8651","2413-354X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321518","host_organization_name":"African Journals OnLine","host_organization_lineage":["https://openalex.org/P4310321518"],"host_organization_lineage_names":["African Journals OnLine"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal de la Recherche Scientifique de l\u2019Universit\u00e9 de Lom\u00e9","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043951576","display_name":"AA Patassi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AA Patassi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026671187","display_name":"A Kotosso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Kotosso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038052973","display_name":"Moun\u00e9rou Salou","orcid":"https://orcid.org/0000-0002-5749-9354","observed_orcids":["https://orcid.org/0000-0002-5749-9354"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Salou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110799151","display_name":"L.D. Baw\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L.D. Baw\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003697928","display_name":"Anne Krivine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Krivine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003934388","display_name":"M Ephrem","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Ephrem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068734128","display_name":"T Blatome","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Blatome","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062751146","display_name":"A Kouvahey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Kouvahey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053580384","display_name":"Dominique Salmon","orcid":"https://orcid.org/0000-0003-1229-2429","observed_orcids":["https://orcid.org/0000-0003-1229-2429"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Salmon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"17","issue":"3","first_page":"685","last_page":"692"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-b-virus","display_name":"hepatitis B virus","score":0.7279999852180481},{"id":"https://openalex.org/keywords/hiv-hbv-coinfection","display_name":"HIV/HBV coinfection","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hbsag-seroprevalence","display_name":"HBsAg prevalence","score":0.7739999890327454},{"id":"https://openalex.org/keywords/hbv-genotypes","display_name":"HBV genotypes","score":0.37299999594688416},{"id":"https://openalex.org/keywords/lamivudine-resistance","display_name":"lamivudine resistance","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hbv-genotyping","display_name":"HBV genotyping","score":0.5450000166893005},{"id":"https://openalex.org/keywords/hbv-viral-load","display_name":"HBV DNA viral load","score":0.4819999933242798},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/resource-limited-settings","display_name":"resource-limited settings","score":0.5550000071525574},{"id":"https://openalex.org/keywords/togo","display_name":"Togo","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hepatitis-b-vaccination","display_name":"hepatitis B vaccination","score":0.4000000059604645},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.5120000243186951},{"id":"https://openalex.org/keywords/hbeag","display_name":"HBeAg","score":0.5720000267028809},{"id":"https://openalex.org/keywords/anti-hbc-antibodies","display_name":"anti-HBc antibodies","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.7221484780311584},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6325530409812927},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6119523644447327},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.22133591771125793}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2467389923","doi":null,"is_oa":false,"landing_page_url":"https://www.ajol.info/index.php/jrsul/article/view/135083","pdf_url":null,"source":{"id":"https://openalex.org/S4212762984","display_name":"Journal de la Recherche Scientifique de l\u2019Universit\u00e9 de Lom\u00e9","issn_l":"1727-8651","issn":["1727-8651","2413-354X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321518","host_organization_name":"African Journals OnLine","host_organization_lineage":["https://openalex.org/P4310321518"],"host_organization_lineage_names":["African Journals OnLine"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal de la Recherche Scientifique de l\u2019Universit\u00e9 de Lom\u00e9","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400402064","https://openalex.org/W2414512236","https://openalex.org/W2803951136","https://openalex.org/W2775563402","https://openalex.org/W924404092","https://openalex.org/W7094950981","https://openalex.org/W7093296830","https://openalex.org/W2783984624","https://openalex.org/W7093348167","https://openalex.org/W4376880027"],"abstract_inverted_index":{"Contexte":[0],":":[1,83,155,207,219,271,326,338,395,457,573],"Le":[2,59,167,193,298],"depistage":[3,299],"de":[4,44,50,61,65,69,88,109,147,172,177,196,203,215,233,274,281,300,308,319],"l\u2019antigene":[5],"HBs":[6,276,302],"n\u2019est":[7],"pas":[8],"systematique":[9],"dans":[10,106,165],"le":[11,191],"bilan":[12],"initial":[13,347],"des":[14,24,94,130,247,286],"patients\u00a0":[15,351],"porteurs":[16,313],"du":[17,77,113,200,212],"VIH":[18],"debutant":[19],"une":[20,231,317],"tritherapie":[21,116],"antiretrovirale.":[22],"L\u2019emergence":[23],"mutants":[25,360],"VHB":[26,38,143,294],"resistants":[27],"a":[28,31,90,133,149,198,279,306,535,610],"la":[29,51,67,70,140,304],"lamivudine":[30,363],"ete":[32,134,163,280],"reconnue":[33],"chez":[34,93,227],"les":[35,41,56,74,145,311],"patients":[36,75,95,103,161,184,229,237,249,287,312,385,466,488,533,552,585,606],"mono-infectes":[37],"traites.":[39],"Or,":[40],"tritherapies":[42],"antiretrovirales":[43],"premiere":[45],"ligne":[46],"au":[47,119,136,277,289],"Togo":[48,278,421,579],"contiennent":[49],"lamivudine,":[52],"doublement":[53],"active":[54],"sur":[55],"deux":[57,157],"virus.":[58],"but":[60],"cette":[62],"etude":[63,84],"est":[64,316],"determiner":[66],"prevalence":[68,232,273,379,536,575],"confection":[71],"VIH/VHB":[72],"parmi":[73],"beneficiaires":[76],"traitement":[78,201],"antiretroviral.":[79],"Methode":[82],"descriptive,":[85,396],"transversale,":[86],"menee":[87],"Mai":[89],"Novembre":[91],"2011,":[92,404],"VIH+,\u00a0":[96],"\u00e2ges":[97],"de18":[98],"ans":[99,179],"et":[100,144,284,303],"plus.":[101],"Les":[102],"etaient":[104],"suivis":[105],"4":[107],"centres":[108],"prise":[110],"en":[111],"charge":[112,141],"Togo,":[114],"sous":[115],"antiretrovirale":[117],"depuis":[118],"moins":[120,290],"six":[121,428,543],"mois,":[122],"ayant":[123],"donne":[124],"un":[125,183,241,253,261,291],"consentement":[126],"ecrit.":[127],"La":[128,272],"detection":[129],"marqueurs":[131],"serologiques":[132],"realisee":[135],"laboratoire":[137],"Biolim":[138,443],"(Togo),":[139,444],"virale":[142],"tests":[146],"sensibilite":[148],"Cochin":[150,452],"(Paris).":[151,453],"Resultats":[154],"Mille":[156],"cent":[158,246],"vingt-quatre":[159],"(1224)":[160,465],"ont":[162,288],"inclus":[164],"l\u2019etude.":[166],"sexe":[168],"ratio\u00a0":[169],"(H/F)":[170],"etait":[171,202,225],"0,3":[173],"(284/866),":[174,480],"l\u2019\u00e2ge":[175],"moyen":[176,195],"41":[178,483],"(21-79":[180,485],"ans).":[181],"Vingt":[182],"(1,7%)":[185],"avaient\u00a0":[186],"declare":[187],"etre":[188],"vaccines":[189],"contre":[190],"VHB.":[192],"taux":[194],"CD4":[197,497],"l\u2019initiation":[199],"144\u00a0":[204],"cell/ml":[205],"[extremes":[206,218],"0":[208,508],"-":[209,221,509,523],"630],":[210,510],"celui":[211],"dernier":[213],"controle":[214],"369":[216,517],"cel/ml":[217],"2":[220,522],"2000].\u00a0":[222],"L\u2019antigene(HBs)":[223],"AgHBs":[224,315],"positif":[226,256,264],"117":[228,532],"soit":[230],"10%.":[234],"Parmi":[235],"ces":[236],"co-infectes,":[238],"seize":[239],"avaient":[240,252],"AgHBe":[242],"positif.":[243],"Soixante-quinze":[244],"pour":[245,310],"1107":[248,551],"dont":[250],"l\u2019AgHBs-":[251],"anticorps":[254,262],"antiHBc":[255],"(AC":[257,265],"anti-HBc+)":[258],";":[259],"23,3%":[260],"antiHBs":[263],"anti-":[266],"HBs+).":[267],"Conclusion":[270,572],"l\u2019Ag":[275,301],"10":[282],"%":[283],"81,5%":[285],"marqueur":[292],"d\u2019infection":[293],"ancienne":[295],"ou":[296],"active.":[297,596],"mise":[305],"disposition":[307],"tenofovir":[309,604],"d\u2019un":[314],"priorite":[318],"sante":[320],"publique.":[321],"Mots":[324],"cles":[325],"Prevalence,":[327,618],"serologie,":[328],"HIV.":[329,620],"English":[332],"Abstract":[333],"Background":[337],"Screening":[339,597],"for":[340,425,598,605],"HBsAg":[341,528,577,599,608],"is":[342,375,609],"not":[343],"systematic":[344],"in":[345,367,405,417,440,451,469,531,578],"the":[346,378,387,441,470,513,601],"evaluation":[348],"of":[349,358,373,380,389,435,512,516,537,550,576,584,591,603],"HIV":[350,382,406],"commencing":[352],"antiretroviral":[353,390,423],"triple":[354],"therapy.":[355],"The":[356,371,472,495,525,574],"emergence":[357],"HBV":[359,368,384,448,592],"resistant":[361],"to":[362,376,402],"has\u00a0":[364],"been":[365],"recognized":[366],"mono-infected":[369],"patients.":[370],"purpose":[372],"this":[374],"determine":[377],"making":[381],"/":[383,476,505,519],"among":[386],"beneficiaries":[388],"therapy":[391,424],"Method":[394],"cross-sectional":[397],"study":[398],"conducted":[399,439],"from":[400],"May":[401],"November,":[403],"+":[407,561,568],"patients,":[408,542],"aged":[409],"18":[410],"years":[411,484],"and":[412,447,462,582,600],"older.":[413],"Patients":[414],"were":[415,467],"followed":[416],"four":[418,464],"care":[419],"centers":[420],"under":[422],"at":[426,499,587],"least":[427,588],"months,":[429],"having":[430],"given":[431],"written":[432],"consent.":[433],"Detection":[434],"serological":[436],"markers":[437],"was":[438,478,502,529,580],"laboratory":[442],"viral":[445],"load":[446],"susceptibility":[449],"testing":[450],"Results":[456],"One":[458],"thousand":[459],"two":[460],"hundred":[461],"twenty":[463],"included":[468],"study.":[471],"sex":[473],"ratio":[474],"(M":[475],"F)":[477],"0.3":[479],"average":[481],"age":[482],"years).":[486],"Twenty-one":[487],"(1.7%)":[489],"reported":[490],"being":[491],"vaccinated":[492],"against":[493],"HBV.":[494],"mean":[496],"count":[498],"treatment":[500],"initiation":[501],"144":[503],"cells":[504],"mL":[506,520],"[range:":[507,521],"one":[511,589],"last":[514],"inspection":[515],"cel":[518],"2000].":[524],"antigen":[526],"(HBsAg)":[527],"positive":[530,554,564],"or":[534,595],"9.6%.":[538],"Among":[539],"these":[540],"co-infected":[541],"had":[544,557,586],"HBeAg":[545],"positive.":[546],"Sixty":[547],"five":[548],"percent":[549],"with":[553,607],"anti-HBc":[555],"AgHBs-":[556],"an":[558],"antibody":[559],"(anti-HBc":[560],"AC);":[562],"23.3%":[563],"anti-HBs":[565],"antibodies":[566],"(anti-HBs":[567],"AC).":[569],"9,6%":[581],"81.5%":[583],"marker":[590],"infection":[593],"former":[594],"provision":[602],"public":[611],"health":[612],"priority.":[613],"Keywords:":[616],"serology,":[619]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-07-22T00:00:00"}